Download
Download by
Scanning QR Code
  • Download app

    Download app

  • Online Inquiry

    Log in to access Online Inquiry
+
Congratulations
You've successfully got advanced quotes worth 5000 HKD
Download APP >>
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Futubull > Quotes > 01093 CSPC PHARMA > Detailed Quotes

01093 CSPC PHARMA

Watchlist
8.320
-0.180-2.12%
Closed  12/09 16:08 CCT
High
8.510
Open
8.480
Turnover
1.52B
Low
8.130
Pre Close
8.500
Volume
183.91M
Market Cap
99.28B
P/E(TTM)
15.07
52wk High
10.360
Shares
11.93B
P/E(Static)
14.47
52wk Low
6.850
Float Cap
99.28B
Bid/Ask %
35.64%
Historical High
13.249
Shs Float
11.93B
Volume Ratio
1.57
Historical Low
-1.249
Dividend TTM
0.2
Div Yield TTM
0.18
P/B
3.03
Dividend LFY
2.40%
Div Yield LFY
2.16%
Turnover Ratio
1.54%
Amplitude
4.47%
Avg Price
8.275
Lot Size
2000
Float Cap
99.28B
Bid/Ask %
35.64%
Historical High
13.249
Shs Float
11.93B
Volume Ratio
1.57
Historical Low
-1.249
Dividend TTM
0.2
P/B
3.03
Dividend LFY
2.40%
Turnover Ratio
1.54%
Amplitude
4.47%
Avg Price
8.275
Lot Size
2000
Price Forecast

News

Comment

Company Overview More
Stone Pharmaceutical Group Limited ("Stone Pharmaceutical Group") is a leader in China's pharmaceutical industry. The company was listed on the main board of the Stock Exchange of Hong Kong in 1994 and is one of the well-known pharmaceutical listed companies in Hong Kong. it is now one of the Hang Seng Composite Index, Hang Seng Hong Kong Chinese Enterprises Index and Hang Seng mainland China 100 stocks. Stone Pharmaceutical Group has three business sectors: innovative drugs, general pharmaceuticals and API drugs, which are mainly engaged in the development, production and sales of medicines and related products. Proprietary medicine products mainly include antibiotics, cardio-cerebrovascular drugs, antipyretic and analgesic drugs, digestive system drugs, antineoplastic drugs and proprietary Chinese medicines, and so on. Among them, "Enbipu", "Oleining", "Xuanning", "Duomesu", "Jin Youli" and "Nuolining" are the best-selling innovative drug products in China. API products mainly include antibiotics, vitamin C and caffeine series. Shiyao Group's main production base is located in Shijiazhuang City, Hebei Province, China. Evaluated by the World Brand Laboratory, one of the top five brand value evaluation institutions in the world, the "Stone Medicine" brand has been selected as the "500 most valuable Brand in China" for 11 times since 2004. In terms of fulfilling its social responsibility, Shiyao Group always takes the lead in supporting social welfare undertakings enthusiastically, and is always indispensable in activities such as SARS, Indonesian tsunami, Wenchuan earthquake, Yushu earthquake, medical treatment of seriously ill children, voluntary services, and so on. With real things, Stone Pharmaceutical Group continues to give back to the community.
CEO: Dongchen Cai
Market: Hong Kong motherboard
Listing Date: 06/21/1994
Futu Hot List
HKUSCN
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist